FDX
40
3
BDX
44
-2
FLR
43
10
ALLE
35
3
F
48
6
AKAM
37
2
GIS
41
-3
KIM
48
-6
PYPL
31
6
VRSK
61
-2
HSY
51
-2
LEG
37
6
DRI
63
-3
TXN
38
3
GME
59
3
HPE
38
4
VLO
50
18
VMC
48
10
XYL
45
-7
INTC
47
4
FDX
40
3
BDX
44
-2
FLR
43
10
ALLE
35
3
F
48
6
AKAM
37
2
GIS
41
-3
KIM
48
-6
PYPL
31
6
VRSK
61
-2
HSY
51
-2
LEG
37
6
DRI
63
-3
TXN
38
3
GME
59
3
HPE
38
4
VLO
50
18
VMC
48
10
XYL
45
-7
INTC
47
4
Financhill
Back

Matthews Emerging Markets Equity Active ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
62

MEM
Matthews Emerging Markets Equity Active ETF

Last Price:
$30.59
Seasonality Move:
2.77%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.31
Seasonality Move:
1.75%
Buy
62
Matthews Emerging Markets Equity Active ETF (MEM) is a Buy

Is Matthews Emerging Markets Equity Active ETF a Buy, Sell or Hold?

  • The current Matthews Emerging Markets Equity Active ETF [MEM] share price is $30.48. The Score for MEM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • MEM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MEM Stock Price Chart

What is Matthews Emerging Markets Equity Active ETF's stock price today?

  • The Matthews Emerging Markets Equity Active ETF share price today is $30.48
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MEM is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

MEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.17 Buy
Relative Strength Index (14 RSI): 63.58 Buy
Chaikin Money Flow: 6730 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.65 - 29.87) Buy
Bollinger Bands (100): (29.5 - 33.14) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

MEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.92 Buy
20-day SMA: 29.48 Buy
50-day SMA: 29.88 Buy
200-day SMA: 30.83 Sell
8-day EMA: 29.98 Buy
20-day EMA: 29.66 Buy
50-day EMA: 29.95 Buy
200-day EMA: 30.34 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Matthews Emerging Markets Equity Active ETF Earnings Growth & MEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Matthews Emerging Markets Equity Active ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):